Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2009
10/13/2009US7601801 polypeptide with binding to antigen and is recognized by cytotoxic T lymphocytes; use as cancer vaccine
10/13/2009US7601535 For in vitro cell culture which contain substantially saturated amounts of selected amino acids; improved exogenous gene expression; also extends cell longevity
10/13/2009US7601516 Follicle stimulating hormone-immunoglobulin fusion fo use in treatment of reproductive disorders
10/13/2009US7601508 Ecdysone receptor polypeptide from the homopteran whitefly (Bamecia argentifoli, BaEcR) use screening for monoclonal antibodies; biological insecticides
10/13/2009US7601354 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/13/2009US7601353 Peptide-based passive immunization therapy for treatment of atherosclerosis
10/13/2009US7601352 Monoclonal antibodies and antigen binding fragments thereof capable of binding TrkA and inhibiting the functional activation of TrkA
10/13/2009US7601350 Antibodies that bind M. tuberculosis polypeptides
10/13/2009US7601349 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein
10/13/2009US7601348 Analyzing distribution of GlcNAc-6-sulfotransferase isozymes, sulfation enzymes of sugar residues; immunoassay
10/13/2009US7601332 Vitamin receptor binding drug delivery conjugates
10/13/2009CA2236888C Medicament, in particular for modulation of the immune response in the control of viruses, tumors, bacteria and parasites
10/13/2009CA2224413C Immunovectors for the intracellular and intranuclear transport
10/13/2009CA2222650C Tnf-.alpha. converting enzyme
10/13/2009CA2220339C Toxin conjugates having a spacer comprising polyalkylene glycol and peptide
10/08/2009WO2009124109A1 Human monoclonal antibodies specific for cd22
10/08/2009WO2009123225A1 Composition, kit and method for detecting neuropathy
10/08/2009WO2009123224A1 Composition, kit and method for detecting aging and disease associated with vascular disorder
10/08/2009WO2009123188A1 Partial peptide of survivin presented on mhc class ii molecule and use thereof
10/08/2009WO2009123145A1 Parasporin-1 receptor and use thereof
10/08/2009WO2009122714A1 Method for detection of pneumococcus
10/08/2009WO2009121948A2 Single domain antibodies capable of modulating bace activity
10/08/2009WO2009121847A2 Binding agents directed against il-4 receptor for the treatment of tumors, inflammatory and immunological disorders
10/08/2009WO2009121804A1 Drug fusions and conjugates
10/08/2009WO2009121690A1 Agent for treating disease
10/08/2009WO2009094006A3 Bordetella outer-membrane protein antigens and methods of making and using the same
10/08/2009WO2009089399A3 Compositions comprising toll-like receptor or coreceptor antagonists and methods for ocular neuroprotection
10/08/2009WO2008104385A8 Method for the treatment of amyloidoses
10/08/2009US20090255004 G-Protein Coupled Receptor and Uses Therefor
10/08/2009US20090253902 Isolation of a rearranged human immunoglobulin gene from a chimeric mouse and recombinant production of the encoded immunoglobulin
10/08/2009US20090253899 Reconstituted polypeptides
10/08/2009US20090253897 Structural protein of adeno-associated virus with modified antigenicity, its production and its use
10/08/2009US20090253777 Methods of diagnosing and treating hyperproliferative disorders
10/08/2009US20090253770 Target gene mimitin of myc
10/08/2009US20090253639 Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases
10/08/2009US20090253626 50 Human Secreted Proteins
10/08/2009US20090253619 Novel peptide involved in energy homeostasis
10/08/2009US20090253200 Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders
10/08/2009US20090253179 Permitting the increased production of recombinant proteins; culturing; introducing into the cells agents that inhibit senescence or that promote cell survival
10/08/2009US20090253175 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments
10/08/2009US20090253146 Methods of expressing integrin beta6 subunits
10/08/2009US20090253144 Methods of assessing dna damage
10/08/2009US20090253132 Mutated acvr1 for diagnosis and treatment of fibrodyplasia ossificans progressiva (fop)
10/08/2009US20090253125 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
10/08/2009US20090252761 Papilloma virus vaccine
10/08/2009US20090252750 Antibodies and immunotoxins that target human glycoprotein nmb
10/08/2009US20090252749 Compositions and Methods for Producing a Composition
10/08/2009US20090252748 Sp35 Antibodies and Uses Thereof
10/08/2009US20090252747 Immunization; used to elicit a humoral or cellular immune response
10/08/2009US20090252746 Erythropoietin receptor binding antibodies
10/08/2009US20090252744 Methods for Treating Bone Cancer Pain by Administering A Nerve Growth Factor Antagonist antibody
10/08/2009US20090252743 Antibody for use in the treatment of crohn's and inflammatory diseases such as ankylosing spondylitis; human tumor necrosis factor alpha (TNF) inhibitors
10/08/2009US20090252742 IL3Ralpha antibody conjugates and uses thereof
10/08/2009US20090252741 Human monoclonal anti-ctla4 antibodies in cancer treatment
10/08/2009US20090252738 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
10/08/2009US20090252737 T Cell Regulatory Genes And Methods Of Use Thereof
10/08/2009US20090252736 Mammalian Genes; Related Reagents
10/08/2009US20090252735 Novel Peptides for Development of Diagnostic and Therapeutic Agents and Methods of Using Same
10/08/2009US20090252734 Antihuman alpha 9 Integrin Antibody and use of the Same
10/08/2009US20090252733 Generation and Profiling of Fully Human Gold-Derived Therapeutic Antibodies Specific for Human CD38
10/08/2009US20090252732 Variable region sequences of il-31 monoclonal antibodies and methods of use
10/08/2009US20090252731 Multivalent Carriers of Bi-Specific Antibodies
10/08/2009US20090252729 Single-chain Fc (scFc) regions, binding polypeptides comprising same, and methods related thereto
10/08/2009US20090252728 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
10/08/2009US20090252727 Glucagon receptor antagonists
10/08/2009US20090252726 Antibodies for inhibiting blood coagulation and methods of use thereof
10/08/2009US20090252724 Antibodies Against Amyloid Beta 4 With Glycosylated in the Variable Region
10/08/2009US20090252723 Remedy for endometriosis
10/08/2009US20090252722 Botulinum Neurotoxin a Protein Receptor and Uses Thereof
10/08/2009US20090252721 Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer
10/08/2009US20090252683 Composition Comprising Cross-Species-Sepecific Antibodies and uses Thereof
10/08/2009US20090252681 Nanobodies and Polypeptides Against EGFR and IGF-IR
10/08/2009CA2720053A1 Composition, kit and method for assaying neuropathy
10/08/2009CA2720051A1 Composition, kit, and method for assaying ageing and disease accompanied with vascular disorder
10/08/2009CA2720039A1 Method for detection of pneumococcus
10/08/2009CA2720025A1 Novel antibodies against cancer target block tumor growth, angiogenesis and metastasis
10/08/2009CA2720013A1 Single domain antibodies capable of modulating bace activity
10/08/2009CA2719964A1 Partial peptide of survivin presented on mhc class ii molecule and use thereof
10/08/2009CA2718480A1 Drug fusions and conjugates
10/08/2009CA2718184A1 Agent for treating disease
10/07/2009EP2107374A1 Polypeptide for diagnosis of vaccination
10/07/2009EP2107128A2 Novel polynucleotides
10/07/2009EP2107115A1 Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2
10/07/2009EP2107109A1 Recombinant vascular endothelial cell growth factor D (VEGF-D)
10/07/2009EP2107071A2 Anti-EpCAM immunoglobulins
10/07/2009EP2107070A1 Rheumatoid arthritis remedy containing IL-6 antagonist as active ingredient
10/07/2009EP2106804A2 Composition and method for detection of pre-metastatic sites
10/07/2009EP2106800A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
10/07/2009EP2106446A1 Stabilization of cyclic peptide structures
10/07/2009EP2106442A1 Cancerous disease modifying antibodies
10/07/2009EP2106441A1 Cancerous disease modifying antibodies
10/07/2009EP2106261A2 Antagonists of pcsk9
10/07/2009EP1505075B1 Antibody to human insulin-like growth factor
10/07/2009EP1434791B1 Specific binding agents of human angiopoietin-2
10/07/2009EP1421112B1 Novel serine protease
10/07/2009EP1317285B1 Methods for treating demyelinating diseases
10/07/2009EP1191099B1 Novel polypeptide and dna thereof
10/07/2009EP1187917B1 Cd44 splice variant associated with rheumatoid arthritis
10/07/2009EP0907735B2 Modulators of tissue regeneration
10/07/2009EP0907730B1 Haemopoietin receptor and genetic sequences encoding same
1 ... 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 ... 1494